Background: Among physicians who perform endoscopic retrograde cholangiopancreatography (ERCP), the relationship between procedure volume and outcome is unknown.
T here is an increasing emphasis on improving quality of care by implementing minimum volume standards for high-risk procedures. An inverse relationship between provider or facility volume and outcomes has been established for a variety of procedures including upper endoscopy, 1 colonoscopy, [2] [3] [4] hepatobiliarypancreatic surgery, 5, 6 and inpatient management of chronic diseases such as congestive heart failure. 7 The study of volume-outcome relationships has led to minimum volume standards in coronary artery bypass graft surgery. 8, 9 Intuitively, all high-risk procedures should require a minimum volume standard; however, there are considerable knowledge gaps in certain fields, including endoscopic retrograde cholangiopancreatography (ERCP).
ERCP is one of the most technically complex and high-risk endoscopic procedures, the volume-outcome relationship for which is incompletely understood. [10] [11] [12] [13] [14] [15] [16] Despite a paucity of data on the topic, experts generally agree that lower volume (endoscopist and facility) is associated with higher failure rates. 17 Therefore, quantifying the volumeoutcome relationship for potential targeting of system redesign is increasingly important as US health care policy transitions to a value-based reimbursement or pay-for-performance system. 18 We sought to quantify the relationship between endoscopist volume and failure rates using a regional health information exchange. Our primary aim is to compare failure rates between providers of varying ERCP volume while adjusting for potential confounders. Secondary aims include a presentation of other quality measures, including the rate of diagnostic-only ERCP, postprocedure hospitalization, and 30-day mortality.
METHODS

Study Design and Population
We conducted a retrospective cohort study of ERCP procedures identified using insurance claims data derived from the Indiana Network for Patient Care (INPC), a nationally recognized regional health information exchange. 19 Claims data are not restricted to INPC hospitals and include public (Indiana Medicaid) and commercial insurers. On the basis of membership in Indiana Medicaid and commercial insurance providers included in this cohort, we estimate that 2.28 million Indiana residents (35% of the state population) are represented. Besides insurance claims data, the INPC includes electronic health records data for many facilities ranging from large academic referral centers to community hospitals. Payer claims for ERCP procedures between January, 2001 and December, 2011 were identified using Current Procedural Terminology, edition 4 codes and the International Classification of Diseases, 9th edition (ICD-9), with each ERCP classified as a distinct event. We validated coding accuracy for the index ERCP and capture of the second ERCP by manual record review of 150 medical records. The study was approved by the Indiana University Office of Research Administration and by the Indiana Office of Medicaid Policy and Planning.
Provider Classification
Endoscopists included gastroenterologists and general surgeons who were classified by their average annual ERCP volume. The list of providers was manually reviewed by 3 physicians to verify that each provider performed ERCP. To confirm balanced data capture across all providers, we present the average annual number of patient encounters (ie, all office visits and endoscopic procedures) and number of individual patients having at least 1 encounter with the provider. Additional data included patient demographics, inpatient or outpatient status at the time of ERCP, and procedure indication (defined using ICD-9 codes).
Outcome Measures
The primary outcome was the post-ERCP failure rate, defined as the composite frequency of the following interventions within 7 days of the index ERCP: having a second (ie, repeat) ERCP, percutaneous transhepatic cholangiogram (PTC), or surgery with exploration of the biliary tree (excluding cholecystectomy alone). Although one or more of these events does not necessarily equate with a negative outcome, the authors agreed on this composite definition a priori as the frequency of any or all of these events would be negligible if the index ERCP is successful from a diagnostic and therapeutic perspective. The proportion of ERCPs having each of these events is presented individually and as a composite frequency. To avoid double-counting, an index ERCP was defined as an ERCP with no other ERCPs performed within the preceding 30 days. Other than failure rates, additional quality measures included the frequency of purely diagnostic ERCP, defined as an ERCP solely associated with Current Procedural Terminology, edition 4 code 43260; postprocedure hospitalization; and all-cause 30-day mortality. We present the frequency and outcomes specific to diagnostic-only ERCP as improvements in less invasive pancreatobiliary imaging, such as endoscopic ultrasound and magnetic resonance cholangiopancreatography have nearly eliminated the need for diagnostic-only ERCP. For example, these less invasive imaging tests are preferred to ERCP for patients with a low or moderate suspicion for choledocholithiasis; if a common bile duct stone is not visualized, ERCP and its inherent risks can be avoided. 20 
Procedure Classification
Each ERCP may have >1 associated indication (eg, gallstone disease + cholangitis). As an ERCP performed for bile duct diagnosis and therapy is generally considered less complex and has a lower risk profile, indications are grouped into biliary and "other" categories when possible. 21 "Biliary indications" were restricted to ICD-9 codes specific to bile duct pathology: gallstones, bile duct injury or obstruction, cholangitis, and pancreatobiliary malignancy. All other indications, such as acute and chronic pancreatitis, were classified as "other" as the procedure may have been performed for bile duct pathology, pancreatic duct pathology, or both. A table of procedure indications with associated ICD-9 codes is available ( 
Statistical Analysis
The nature of the volume-outcome association was investigated by fitting a smooth curve on the empirical Bayes estimates of the failure rate using the nonparametric local regression (local regression smoothing technique) smoothing technique, where the smoothing parameter was selected by the corrected Akaike Information Criterion. 22 The empirical Bayes estimates of the failure rates were estimated based on the logistic regression model with provider-specific random effects where provider volume was modeled as a continuous variable. Providers were then classified by their INPC annual ERCP volume into 2 relative volume categories, based on the smooth curve that describes the association between provider volume and failure outcome. We present patient, provider and ERCP characteristics along with predefined outcomes using descriptive statistics. Continuous variables are summarized using mean and SD if the distribution is roughly symmetric and using median and the 25th and 75th percentiles otherwise. Categorical variables are described using frequency and proportion. Comparison of these characteristics between provider groups is performed using t tests for provider characteristics and using mixed models with provider-specific random effects for patient and ERCP characteristics/outcomes. Mixed modeling accounts for intraprovider correlation and stabilizes the estimates of provider effects, especially for providers with a small number of ERCPs.
To account for differences in patient characteristics (age, sex, race, inpatient status at the time of ERCP, comorbidity index), provider characteristics (years since primary board certification and annual volume), and ERCP indication that might have contributed to the observed differences in failure rates across provider groups, these factors were included as covariates in a multivariable model for predicting failure. The multivariable logistic regression model with provider-specific random effects was used to determine the association between provider volume and procedure failure while controlling for the effects of patient-level and provider-level covariates. Results are presented using odds ratios (OR), the corresponding 95% confidence intervals (CI), and P values. For each volume strata, the OR represents the odds of procedure failure for every additional ERCP performed per year.
RESULTS
Distribution of ERCP Services in Indiana
During the 11-year study period we identified 16,968 ERCPs performed by 130 providers. Of these, 15,514 met criteria for an "index ERCP," whereas 1454 (8.6%) had a prior ERCP performed within 30 days. We validated 96% of index ERCPs and 97% of second ERCPs performed within 7 days of the first ERCP. On the basis of the piecewise linear relationship of relative annual volumes and associated failure rates revealed by the local regression smoothing technique smooth curve, a cut-off of 25 ERCPs/year was used to dichotomize providers into low (< 25/y) and high (Z25/y) ( Figs. 1A, B ). There was no difference in the annual number of distinct patient encounters (combination of ERCP and non-ERCP procedures and clinic visits), a surrogate marker of provider-specific clinical activity, captured in the INPC between low-volume and high-volume groups (P = 0.762), suggesting balanced data capture across these groups ( Table 1 ). The majority of providers in both volume groups were gastroenterologists and board-certified. Provider experience, defined as number of years since primary board certification as of 2011, was similar in both the groups. The geographic distribution of these providers is illustrated ( Figure, 
Patient and Procedure Characteristics
Patients undergoing ERCP by a low-volume provider were more likely to be male (P < 0.001) but similar in terms of age, inpatient status, and baseline comorbidity as defined using the Charlson Comorbidity Index 23 (Table 1) . Although inpatient status at the time of ERCP was similar, patients undergoing ERCP by a low-volume provider were more likely to have been admitted 1 day before the procedure (P = 0.001) ( Table 1) .
Low-volume providers more frequently performed ERCPs for a biliary indication (70.2% vs. 60.3% among highvolume providers), but this did not reach statistical significance (P = 0.224) ( Table 2 ). However, the proportion of ERCPs performed for acute cholangitis (which typically requires ERCP within 24 h of presentation) was small in both groups (low = 2.0%, high = 3.0%; P = 0.082). High-volume providers performed ERCP for bile duct injury, another biliary indication often requiring intervention within 24 hours, more often (0.4%) than the low-volume group (0.2%, P = 0.216). ERCPs having other indications-those not definitively specific to the biliary tree-were more frequently performed by high-volume providers (72.5% vs. 59.7% among low volume; P = 0.015). Chronic pancreatitis (P < 0.001), sphincter of Oddi dysfunction Each procedure may have >1 indication, so numbers do not add up to 100%. Odds ratio represents the odds of having a failed procedure for an increase in annual ERCP volume of n = 1 among low-volume and high-volume physicians, respectively. For example, among low-volume physicians performing an ERCP for gallstone disease, the odds of having a failed procedure are 3.3% lower for each increase of 1 ERCP per year.
With the exception of bile duct obstruction, the odds of having a failed procedure did not significantly change among high-volume providers per unit increase in ERCP volume. ERCP indicates endoscopic retrograde cholangiopancreatography; NOS, not otherwise specified.
(P = 0.006), and other pancreatic pathology (P < 0.001) were substantially more common indications for ERCPs performed by high-volume physicians. Specific indications for ERCP were not associated with greater odds of having a failed procedure among high-volume physicians ( Table 2) ; in this subgroup, increasing physician volume led to a clinically small but statistically significantly higher chance of failure for ERCPs performed for bile duct obstruction (OR, 1.007; P = 0.040), while no other indication was sensitive to changes in physician volume. However, among low-volume physicians, increasing annual volume was associated with significantly lower odds of a failed ERCP when performed for gallstone disease (OR, 0.967; P = 0.004), other bile duct/liver pathology (OR, 0.963; P = 0.002), bile duct obstruction (OR, 0.966; P = 0.014), abdominal symptoms (OR, 0.956; P < 0.001), or abnormal laboratory parameters (OR, 0.956; P = 0.001).
Failure Rates and Other Quality Measures
The post-ERCP failure rate, defined as a patient requiring a second ERCP, PTC, or surgical exploration of the bile duct r7 days after the index ERCP, was significantly higher among low-volume (9.5%) compared with high-volume (5.7%, P < 0.001) providers ( Table 3 ). The composite rate of early-repeat ERCP, PTC, and surgery with bile duct exploration (Figs. 1A, B ) illustrates the piecewise linear volume-outcome relationship. Similarly, the incidence of early (r7 d) repeat ERCP (a subgroup of the definition of procedure failure) was inversely proportional to provider annual volume: low = 4.1%, high = 2.3% (P = 0.013). The frequency of diagnostic-only ERCP was significantly higher among low-volume (15.8%) compared with high-volume providers (7.8%, P = 0.016).
Among patients who underwent the procedure as an outpatient, the incidence of immediate hospitalization (defined as hospitalization within 24 h of the procedure) was significantly higher among low-volume (28.3%) as compared with high-volume providers (14.8%, P = 0.002). Among patients hospitalized immediately after the ERCP, the length of hospitalization was similar between groups (P = 0.899). Similarly, the rates of hospitalization within 30 days of the index ERCP were significantly lower among the highest volume physicians (P = 0.023). However, average length of stay was significantly longer for patients admitted within 30 days of ERCP by a high-volume provider (P = 0.001), suggesting higher baseline morbidity among the subgroup requiring hospitalization. Mortality rates within 30 days of the index ERCP were similar between groups (P = 0.455).
Factors associated with greater odds of procedure failure included male sex (OR, 1.257; 95% CI, 1.097-1.440), inpatient status at the time of the procedure (OR, 1.521; 95% CI, 1.315-1.759), and having a Charlson score Z1 (OR, 1.398; 95% CI, 1.058-1.848) ( Table 4 ). ERCP indications associated with greater odds of failure included gallstone disease (P = 0.028) and bile duct obstruction (P < 0.001), whereas acute pancreatitis (P = 0.008) and chronic pancreatitis (P = 0.001) were associated with a lower failure rate. Physician experience, defined as years since initial board certification, was not significantly associated with a lower rate of failure (P = 0.441). Among low-volume physicians, the adjusted odds of a failed procedure were significantly lower with each unit increase in procedure volume (OR, 0.967; 95% CI. 0.950-0.984; P < 0.001). Stated alternatively, for each additional ERCP performed per year by a low-volume provider, the odds of failure decreased by 3.3% (95% CI, 1.6%-5.0%). Differences in procedure volume among high-volume providers did not impact odds of failure (P = 0.997).
CONCLUSIONS
Over the past 2 decades, there has been a slow increase in the number of patients referred for ERCP to an academic medical center after having a failed procedure at a lowervolume facility. 24 Therefore, we emphasize failure rates, frequency of diagnostic-only ERCP, and need for hospitalization as key quality measures in an effort to define the endoscopist volume-outcome relationship. Previous studies z Immediate hospitalization is defined as a hospitalization that occurred within 24 hours of the index ERCP. y Because length of stay is highly skewed to the right, comparisons are based on its logarithmic transform. ERCP indicates endoscopic retrograde cholangiopancreatography; PTC, percutaneous transhepatic cholangiogram. evaluating this relationship are conflicting. [11] [12] [13] [14] 25 These studies are limited by voluntary reporting of outcomes, 14 emphasis on procedural complications that are highly dependent on the preprocedure indication, and sampling frames with small numbers of physicians or facilities. Varadarajulu et al 12 previously reported higher failure rates and longer hospitalizations for ERCPs performed at lower-volume facilities but did not consider individual provider volume. In their study, failure was defined as the need for PTC or bile duct exploration but did not include the rate of early-repeat ERCP, an important measure of incomplete therapy. In addition, Varadarajulu and colleagues restricted their analysis to select ICD-9 codes (cholelithiasis, other disorders of the biliary tract, and diseases of the pancreas) and did not include purely diagnostic ERCPs. In our cohort, failure rates were higher among purely diagnostic ERCPs, presumably because the majority of diagnostic ERCPs represent cases in which one or both ducts can be opacified but the physician is unable to proceed with necessary therapy (eg, sphincterotomy, stone removal, stent placement) for technical reasons. The alternative explanation is that the procedure was performed for diagnosis alone. In either case, a diagnostic-only ERCP represents lower-quality care. Therefore, our observation that rates of purely diagnostic ERCP are higher among low-volume providers is another important measure of quality, as the need for diagnostic ERCP has been obviated by alternative, less invasive imaging modalities. The study by Varadarajulu and colleagues observed a facility volume-outcome relationship that is congruent with our results at the provider level. It is unlikely that correcting for facility volume in our analysis would eliminate the observed provider outcome relationship as provider and facility volume are often closely linked: the majority of low-volume providers perform ERCP typically at low-volume facilities.
There are several compelling reasons that the "value" (ie, outcome for each dollar spent 18 ) of ERCP services in the US is low. First, its utilization has plateaued over the last decade as it has been largely replaced as a purely diagnostic tool by less invasive modalities such as endoscopic ultrasound and magnetic resonance cholangiopancreatography. 26, 27 As a result, there are comparatively fewer procedures to disperse among ERCP providers who need to develop and maintain their technical expertise. Second, the majority (95%) of ERCPs performed in the United States are completed in lower-volume (< 200 per year) facilities. 12 Low-volume units are less efficient than high-volume units, which can achieve a lower average cost. Third, ERCP is performed less frequently than other endoscopic procedures, and is frequently required in an urgent setting (eg, symptomatic choledocholithiasis or obstructive jaundice). Large ( > 5 providers) specialty practices are reluctant to centralize ERCP services in part due to the implications for night and weekend coverage. 28 However, there is almost invariably an opportunity to delay the procedure for a limited time as indications for emergent (< 24 h after presentation) ERCP such as cholangitis (2.6% in our cohort) and some cases of bile duct injury (0.3% in our cohort) are uncommon. As the current US health care delivery system has traditionally incentivized quantity over quality, hospitals pre-sumably choose to offer ERCP to benefit from "downstream revenue": utilization of cross-sectional imaging, surgery, and hospitalization. However, in the era of health care reform and patient-reported outcomes, a more conscious effort to balance cost and quality will continue to evolve. Fourth, ERCP is one of the most technically difficult endoscopic procedures with a high-risk profile, and most gastroenterologists who perform it have limited training due to the aforementioned factors. 28 Finally, as shown in our cohort, the majority (116 of 130, 89%) of physicians performing ERCP do very little of it.
Particular strengths of our study are the inclusion of both commercial and public payers; given the indications for ERCP such as choledocholithiasis, this population is more generalizable than a Medicare population of individuals aged 65 and older. Another advantage is the large sample size across the diverse demography of Indiana, derived from a nationally recognized health information exchange. Our inclusion of all reported indications for ERCP improves the generalizability of the results and underscores that, despite higher failure and postprocedure hospitalization rates, lowvolume providers are more likely to perform ERCP for indications that typically have lower complexity and complication rates. Therefore, it is possible that our observed differences are biased against high-volume providers. However, use of ICD-9 codes to define indications does not necessarily distinguish high-complexity and low-complexity procedures: a 4-mm gallstone that can be easily removed following biliary sphincterotomy would have the same code as a 20-mm stone that requires mechanical or electrohydraulic lithotripsy. Finally, our definition of failure is specific but has lower sensitivity as a substantial group of patients may have required a repeat ERCP, PTC, or bile duct exploration after 7 days due to an unsuccessful index procedure (eg, painless jaundice, choledocholithiasis without acute symptoms). It is very unlikely that we have overestimated the failure rate as a second bile duct intervention in r7 days after ERCP is almost never clinically indicated if the index procedure is successful; specific cases such as Mirizzi syndrome may require surgical exploration after a successful ERCP but this is usually deferred several weeks to allow normalization of cholestatic liver tests. Furthermore, changing the window for failure to 15 or 30 days did not significantly change the results; a significant relationship between low-volume and higher failure rates persisted (data not shown).
There are important limitations to consider. First, we did not quantify the interaction between physician and facility volume as the latter could not be reliably measured. Second, we did not measure other physician-specific factors that may affect outcomes, such as annual volume before the onset of this study and quality of ERCP training. Consistent with our analysis, a previous study of 1335 ERCPs observed lower complication rates from sphincterotomy among higher-volume providers, irrespective of experience, defined as years since training. 29 Third, we do not present rates of ERCP-specific complications such as pancreatitis, gastrointestinal bleeding, cholangitis and bowel perforation; these are expected to correlate with procedure indication more than to our definition of failure. However, our observation that hospitalization rates within 24 hours of the procedure are higher among low-volume providers can be explained either by a tendency among low-volume providers to admit more patients for observation postprocedure or by a higher incidence of postprocedure complications. In either case, higher postprocedure hospitalization rates suggest lower quality of care, excess resource utilization, or both, but require confirmation through more direct study. Finally, although the INPC data are of high quality, 19 it does not capture all ERCPs performed by each provider. Interestingly, we found similar rates of overall clinical productivity, defined as total number of clinical encounters per provider, between the high and low ERCP volume provider groups, which suggests that we are not misclassifying providers as low volume simply on the basis of missing data. We estimate that the observed INPC volumes imply overall annual volumes of <117 ERCPs/year for low-volume providers. However, INPC-specific volumes should not be considered as "thresholds" for future guidelines/recommendations without more direct study. A low-volume cut-off of 117 procedures is consistent with previous studies suggesting lower complication rates among physicians performing >100 ERCPs annually. 29 This has important implications for systems redesign, as we observed similar outcomes for all providers exceeding this threshold.
In conclusion, despite performing ERCP more frequently for indications having greater technical complexity and risk, higher-volume providers have lower failure rates and hospitalization rates compared with lower-volume physicians. The magnitude of this volume-outcome relationship highlights the importance of developing benchmark reports for ERCP outcomes that are provider-specific and facility-specific, as the Gastrointestinal Quality Improvement Consortium developed for colonoscopy. 30 The consequences that ERCP-specific outcome reporting might have upon current patient preferences to receive care locally and the potential to widen or to narrow disparities in care require further investigation. [31] [32] [33] ERCP outcomes may be similar to pancreatectomy, the mortality from which significantly declined as the surgery was performed in more selective centers. 34 In addition to performance transparency, a recent Institute of Medicine report emphasized the need to utilize systems engineering tools and process improvement methods to provide the best care at lower cost. 35 Efforts to concentrate ERCP services among fewer, higher-volume providers may help to achieve this goal. 
